|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 243.07 USD | +0.20% |
|
-1.01% | +18.02% |
| 02:57pm | Johnson & Johnson Wins EU Approval for Akeega in BRCA-Mutated Prostate Cancer | MT |
| 11:09am | Johnson & Johnson Seeks Tecvayli Indication Extension in EU | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Innovative Medicine | 52.08B | 52.56B | 54.76B | 56.96B | 60.4B | |||||
Total Assets | 64.38B | 58.44B | 58.32B | 57.07B | 78.06B | |||||
CAPEX | -1.2B | -1.37B | -1.65B | -1.71B | -2.08B | |||||
EBT | 18.18B | 15.9B | 18.25B | 18.92B | 22.27B | |||||
D&A | 4.03B | 3.69B | 3.85B | 3.76B | 3.77B | |||||
Therapeutic Devices | ||||||||||
Medtech | 27.06B | 27.43B | 30.4B | 31.86B | 33.79B | |||||
Total Assets | 53.37B | 70.96B | 74.71B | 84.32B | 86.48B | |||||
CAPEX | -1.93B | -2.12B | -2.37B | -2.44B | -2.5B | |||||
EBT | 4.37B | 4.61B | 4.67B | 3.74B | 4.11B | |||||
D&A | 2.29B | 2.3B | 2.94B | 3.24B | 3.49B | |||||
Total Assets | 39.19B | 33.92B | 34.52B | 38.71B | 34.67B | |||||
CAPEX | -190M | -192M | -356M | -271M | -255M | |||||
D&A | 316M | 323M | 313M | 342M | 241M | |||||
EBT | -1.07B | -624M | -7.85B | -5.97B | 6.2B | |||||
EBT | - | -1.09B | - | - | - | |||||
Baby Care Products | ||||||||||
Consumer Health | 14.64B | 14.95B | - | - | - | |||||
Total Assets | 25.08B | 24.07B | - | - | - | |||||
CAPEX | -331M | -323M | - | - | - | |||||
EBT | 1.29B | 2.93B | - | - | - | |||||
D&A | 759M | 658M | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 47.16B | 48.58B | 46.44B | 50.3B | 53.75B | |||||
Total Assets | 48.59B | 66.28B | 54.83B | 70.67B | 89.39B | |||||
Total Assets | 1.01B | 1.13B | 1.19B | 1.22B | 1.22B | |||||
Europe | 23.59B | 23.45B | 20.41B | 20.21B | 21.54B | |||||
Total Assets | 43.26B | 38.77B | 31.62B | 27.27B | 27.99B | |||||
Asia-Pacific, Africa | 17.28B | 16.79B | 13.76B | 13.59B | 14.03B | |||||
Total Assets | 5.04B | 4.43B | 1.5B | 1.45B | 1.54B | |||||
Western Hemisphere, Excluding U.S. | 5.75B | 6.12B | 4.55B | 4.71B | 4.88B | |||||
Total Assets | 2.71B | 2.74B | 1.49B | 1.73B | 2.2B | |||||
Total Assets | 1.01B | 1.13B | 1.19B | 1.22B | - | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 81.42B | 74.02B | 76.93B | 77.77B | 76.87B |
- Stock Market
- Equities
- JNJ Stock
- Financials Johnson & Johnson
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















